Rothschild upgrades Abbott to Buy, lifts price target
Alpha Vantage · Benzinga · · AI-summarised by FinFlash
A roundup of ten analyst forecasts features rating changes and price target adjustments across several companies. Rothschild & Co upgraded Abbott Laboratories to Buy and raised its price target, implying upside of more than 31% from its Thursday close. Accenture, CSX, Nike and Marathon Petroleum also received updated ratings and price targets from various analysts. Abbott carries a consensus target of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context